Ruxolitinib prevents irreversible autoimmune endocrinopathies in APECED.

Pechacek J, Webb T, Dos Santos Dias L, Wu R, Moorman H, Barber P, Rosen LB, Burbelo PD, Colton B, Guzman H, Sacta M, McCormack SE, Bennett A, Loomes K, Romberg N, McGrath N, Holland SM, Heller T, Winer KK, Pittaluga S, Lionakis MS

Open source

DOI: 10.1038/s41467-026-76285-x
Published: 2026 Aug 1
Container: Nature communications
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-026-76285-x,
  title = {Ruxolitinib prevents irreversible autoimmune endocrinopathies in APECED.},
  author = {Pechacek J and Webb T and Dos Santos Dias L and Wu R and Moorman H and Barber P and Rosen LB and Burbelo PD and Colton B and Guzman H and Sacta M and McCormack SE and Bennett A and Loomes K and Romberg N and McGrath N and Holland SM and Heller T and Winer KK and Pittaluga S and Lionakis MS},
  year = {2026},
  journal = {Nature communications},
  doi = {10.1038/s41467-026-76285-x},
  url = {https://doi.org/10.1038/s41467-026-76285-x}
}

RIS

TY  - JOUR
TI  - Ruxolitinib prevents irreversible autoimmune endocrinopathies in APECED.
AU  - Pechacek J
AU  - Webb T
AU  - Dos Santos Dias L
AU  - Wu R
AU  - Moorman H
AU  - Barber P
AU  - Rosen LB
AU  - Burbelo PD
AU  - Colton B
AU  - Guzman H
AU  - Sacta M
AU  - McCormack SE
AU  - Bennett A
AU  - Loomes K
AU  - Romberg N
AU  - McGrath N
AU  - Holland SM
AU  - Heller T
AU  - Winer KK
AU  - Pittaluga S
AU  - Lionakis MS
PY  - 2026
JO  - Nature communications
DO  - 10.1038/s41467-026-76285-x
UR  - https://doi.org/10.1038/s41467-026-76285-x
ER  -

APA

J, P., T, W., L, D. S. D., R, W., H, M., P, B., LB, R., PD, B., B, C., H, G., M, S., SE, M., A, B., K, L., N, R., N, M., SM, H., T, H., KK, W., S, P., & MS, L. (2026). Ruxolitinib prevents irreversible autoimmune endocrinopathies in APECED.. Nature communications. https://doi.org/10.1038/s41467-026-76285-x

Source records

pubmed · retrieved 2026-09-26T11:48:49.312Z